Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

EMA And Drug Makers Debate PRIME, Adaptive Pathways, Alzheimer's - And More

This article was originally published in SRA

Executive Summary

Scrip Regulatory Affairs editor Maureen Kenny was at the European Medicines Agency in London on Nov. 19 reporting from a meeting where regulators and drug makers explored the challenges they face and the opportunities ahead.

Advertisement
Advertisement
UsernamePublicRestriction

Register